GUIDANCE - Unknown Company - FDA Guidance: Benefit-Risk Factors to Consider When Determining Substantial Equivalence in Premarket Notifications (510(k)) with Different Technological Characteristics: Guidance for Industry and Food and Drug Administration Staff | Global Key Solutions

GUIDANCE - Unknown Company - FDA Guidance: Benefit-Risk Factors to Consider When Determining Substantial Equivalence in Premarket Notifications (510(k)) with Different Technological Characteristics: Guidance for Industry and Food and Drug Administration Staff | Global Key Solutions | Global Key Solutions